Results 141 to 150 of about 3,191 (210)

Improving the Appropriate Prescribing of Olanzapine for Chemotherapy-Induced Nausea and Vomiting: A Quality Improvement Initiative for the Outpatient Oncology Practice. [PDF]

J Adv Pract Oncol
Gennette RL, Dontje K, Rana J, Fadley S, Issawi E, Krupp R, Bowers H.   +6 more
europepmc   +1 more source

Efficacy of olanzapine for prophylaxis of delayed chemotherapy-induced nausea and vomiting in patients with breast cancer receiving dose-dense AC with a steroid-sparing regimen: a single-center pilot study. [PDF]

BMC Cancer
Tada M, Kikawa Y, Shibata N, Hirai C, Yanai H, Takada M, Sugie T.   +6 more
europepmc   +1 more source

Chemotherapy-induced nausea and vomiting symptom experience in patients with non-small-cell lung cancer: A qualitative study. [PDF]

Medicine (Baltimore)
Cheng J, Xu J, Shi R, Zhu W, Lu M, Mao Y.   +5 more
europepmc   +1 more source

Development and pharmacokinetic evaluation of granisetron hydrochloride buccal tablets for optimized chemotherapy-induced nausea and vomiting (CINV) relief. [PDF]

Front Pharmacol
Thalluri C, Naik Bukke SP, Vasam M, Medhi J, Chettupalli AK, Mamilla Mugaiahgari BK, Narapureddy BR, Yata VK, Chander Thatipelli R.   +8 more
europepmc   +1 more source

Evaluation of the clinical application of histamine H2 receptor antagonists in the prevention of chemotherapy-induced nausea and vomiting based on the attribute hierarchy model method. [PDF]

Front Pharmacol
Song J, Liu L, Meng B, Zhao H, Zhang P, Chen H, Wang Y.   +6 more
europepmc   +1 more source

Effect of enhanced support for coping with side effects during medication counselling on the nocebo effect in patients with advanced lung cancer receiving initial chemotherapy: protocol for a multicentre exploratory open-label randomised controlled trial. [PDF]

BMJ Open
Fujii R, Matsuda Y, Okada M, Ishikura H, Imai Y, Muraoka R, Hasuo H.   +6 more
europepmc   +1 more source

Effectiveness of antiemetic regimens in controlling chemotherapy induced nausea and vomiting during hematopoietic stem cell transplantation. [PDF]

Sci Rep
Suárez-Casillas P, Ciudad-Gutiérrez P, Pérez-Moreno MA, Blázquez-Goñi C, Domínguez FMM, Pérez-Simón JA, Martín LA.   +6 more
europepmc   +1 more source

Olanzapine Plus Triple Antiemetic Therapy for the Prevention of Platinum-Based Delayed-Phase Chemotherapy-Induced Nausea and Vomiting: A Meta-Analysis. [PDF]

Curr Oncol
Gong W, Qie H, Xu Y, Wang P, Gao J, Wang M.   +5 more
europepmc   +1 more source

Development and validation of predictive model for emesis in cervical cancer patients receiving concurrent chemoradiotherapy based on multi-institutional retrospective study. [PDF]

Sci Rep
Yoshida K, Morita H, Nakai M, Kawamura Y, Matsumoto T, Gohara Y, Hoshino N, Tonomura N, Banba M, Yamaguchi A, Tachibana M, Fukushima T, Hosokawa H, Mura T, Yabuki T, Pak K, Watanabe S, Kiyomi A, Hidaka N, Saito C, Kobayashi T, Shoji T, Kaneko M, Koga M, Nozaki T, Sugiura M.   +25 more
europepmc   +1 more source

Bioequivalence of netupitant and palonosetron (NEPA) oral suspension and hard capsules in healthy individuals: results from an open-label, randomized, two-treatment, four-period, two-sequence replicative design trial. [PDF]

Support Care Cancer
Gasanin E, Bezzo R, Spinelli T, Seitz F.
europepmc   +1 more source